Hypericum extract WS® 5570 for depression
This study is recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.
In Germany
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.
In GermanyThis study is recruiting. It focuses on anxiety and currently lists participation information in France.
In ParisThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In TorontoThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In CharlestonThis study is recruiting. It focuses on depression and currently lists participation information in Spain.
In ZaragozaThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in the United States.
In MadisonThis study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In BostonThis study is recruiting. It focuses on depression and currently lists participation information in Indonesia.
In SlemanThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In Chapel HillThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.